title: Design of tuberculosis vaccine trials under financial constraints.
authors.affiliation: a Centro de Investigação em Saúde de Manhiça (CISM) , Maputo , Mozambique.|b ISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB) , Hospital Clínic - Universitat de Barcelona , Barcelona , Spain.|c Amsterdam Institute for Global Health and Development (AIGHD) , Amsterdam , The Netherlands.
authors.forename: Alberto L
authors.initials: AL
authors.lastname: García-Basteiro
authors.affiliation: d Human immunology, Dept. of infectious disease immunology , Statens Serum Institut , Copenhagen , Denmark.
authors.forename: Morten
authors.initials: M
authors.lastname: Ruhwald
authors.affiliation: e Division of Clinical Infectious Diseases , Research Center Borstel , Borstel , Germany.|f German Center for Infection Research , Clinical Tuberculosis Center , Borstel , Germany.|g International Health/Infectious Diseases , University of Lübeck , Lübeck , Germany.|h Department of Medicine , Karolinska Institute , Stockholm , Sweden.|i Department of Internal Medicine , University of Namibia School of Medicine , Windhoek , Namibia.
authors.forename: Christoph
authors.initials: C
authors.lastname: Lange
mesh_terms: D002986:Clinical Trials as Topic / Q000191:economics*; D016527:Drug Costs; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000276:immunology*; D012109:Research Support as Topic / Q000191:economics*; D016896:Treatment Outcome; D014376:Tuberculosis / Q000175:diagnosis / Q000191:economics* / Q000382:microbiology / Q000517:prevention & control*; D032581:Tuberculosis Vaccines / Q000009:adverse effects / Q000191:economics* / Q000276:immunology / Q000627:therapeutic use*
chemical_list: D032581:Tuberculosis Vaccines
keywords: BCG; R&D; Tuberculosis; correlates of protection; vaccine